Dave Bloom
Dave Bloom is CEO and "Blogger in Chief" of SnackSafely.com.
Symjepi, the Once Promising Emergency Epinephrine Device, Continues to Stumble
It's back to square one.
An Open Letter to the CDC on Behalf of Children with Food Allergies: Revise...
A number of non-profit food allergy advocacies have issued a joint letter to the CDC urging them to revise their draft guidance before it is published.
Oral Immunotherapy: What You Should Know, and What’s New (Webinar)
In FARE's webinar you’ll hear the latest on cutting-edge studies on new food allergy treatments.
BREAKING NEWS: Dr Anthony Fauci announces remdesivir will set a new ‘standard of care’...
First drug confirmed to provide significant benefit over placebo in a randomized trial.
Study: Dogs Beneficial in Early Childhood for Prevention of Sensitivities Implicated in Food Allergy
Here's another reason why dogs are man's best friend.
‘Anaphylaxis’, the Music Video Your Teen May Be Watching
Warning: Contains lyrics and video you might find disturbing or objectionable.
Pending Litigation Shows Food Allergy Treatments in Development are Sometimes Overhyped
Drugs — sometimes touted as miracle treatments during development — don't necessarily pan out despite the hype.
Many New Allergy-Friendly Products! Download the Latest Safe Snack Guide (or Create Your Own...
We've added many new products and welcome two new companies to our Manufacturer Partnership.
The Background for FARE’s New Guidance Regarding Anaphylaxis During the COVID-19 Crisis
We provide a link to the original JACI article to foster a better understanding of the rationale behind FARE's decision.
A Message for Food Allergy Sufferers: Now is Not the Time
Two common sense recommendations until the coronavirus crisis abates.
